MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3918-3928

  Jung, Monika ^a   Mollenkopf, Hans Joachim ^b   Grimm, Christina ^c   Wagner, Ina ^b   Albrecht, Marco ^d   Waller, Tobias ^a   Pilarsky, Christian ^e   Johannsen, Manfred ^a   Stephan, Carsten ^a   Lehrach, Hans ^c   Nietfeld, Wilfried ^c   Rudel, Thomas ^d   Jung, Klaus ^a,f   Kristiansen, Glen ^g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^f Berlin Institute for Urologic Research   (Germany)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Clear cell renal cell carcinoma; Microarray; MicroRNA profiling; RT PCR

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY CARCINOMA; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; ONCOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEDICAL ONCOLOGY; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70350755290     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00705.x     Document Type: Article

References (54)

1. Waldman SA, Terzic A. MicroRNA signatures as diagnostic and therapeutic targets. Clin Chem. 2008, 54:943-4.
2. Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer J. 2008, 14:1-6.
3. Calin GA, Dumitru CD, Shimizu M. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002, 99:15524-9.
4. Yanaihara N, Caplen N, Bowman E. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006, 9:189-98.
5. Roldo C, Missiaglia E, Hagan JP. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006, 24:4677-84.
6. Cummins JM, He Y, Leary RJ. The colorectal microRNAome. Proc Natl Acad Sci USA. 2006, 103:3687-92.
7. Iorio MV, Ferracin M, Liu CG. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-70.
8. Murakami Y, Yasuda T, Saigo K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006, 25:2537-45.
9. Ozen M, Creighton CJ, Ozdemir M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008, 27:1788-93.
10. Molnar V, Tamasi V, Bakos B. Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas. Semin Cancer Biol. 2008, 18:111-22.
11. Wu W, Sun M, Zou GM. MicroRNA and cancer: Current status and prospective. Int J Cancer. 2007, 120:953-60.
12. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006, 6:857-66.
13. Waldman SA, Terzic A. Translating MicroRNA discovery into clinical biomarkers in cancer. JAMA. 2007, 297:1923-5.
14. Schetter AJ, Leung SY, Sohn JJ. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008, 299:425-36.
15. Schaefer A, Jung M, Kristiansen G. MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urol Oncol. 2008, 10.1016/j.urolonc.2008.10.021, Epub ahead of print, December 29, doi
16. Jemal A, Siegel R, Ward E. Cancer statistics, 2008. CA Cancer J Clin. 2008, 58:71-96.
17. Gottardo F, Liu CG, Ferracin M. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007, 25:387-92.
18. Dutta KK, Zhong Y, Liu YT. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci. 2007, 98:1845-52.
19. Lu J, Getz G, Miska EA. MicroRNA expression profiles classify human cancers. Nature. 2005, 435:834-8.
20. Shingara J, Keiger K, Shelton J. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA. 2005, 11:1461-70.
21. Chen C, Guegler KJ. MicroRNA quantitation by TaqMan® real-time PCR. MicroRNAs: biology, function and expression 2007, 299-322. Clarke NJ, Sanseau P. In, editors, Eaglerville, DNA Press, pp
22. Nakada C, Matsuura K, Tsukamoto Y. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol. 2008, 216:418-27.
23. Sui W, Dai Y, Huang Y. Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transpl Immunol. 2008, 19:81-5.
24. Lopez-Beltran A, Scarpelli M, Montironi R. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006, 49:798-805.
25. Wong L, Lee K, Russell I. Endogenous controls for real-time quantitation of miRNA using TaqMan® microRNA-assays. Application note 127AP11-01, Applied Biosystems
26. Rajewsky N. microRNA target predictions in animals. Nat Genet. 2006, 38:S8-13.
27. Kuhn DE, Martin MM, Feldman DS. Experimental validation of miRNA targets. Methods. 2008, 44:47-54.
28. Lowery AJ, Miller N, McNeill RE. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res. 2008, 14:360-5.
29. Sassen S, Miska EA, Caldas C. MicroRNA: implications for cancer. Virchows Arch. 2008, 452:1-10.
30. Rosenfeld N, Aharonov R, Meiri E. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008, 26:462-9.
31. Ramaswamy S, Tamayo P, Rifkin R. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA. 2001, 98:15149-54.
32. Gregory PA, Bert AG, Paterson EL. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008, 10:593-601.
33. D'Alessandro V, Muscarella LA, Copetti M. Molecular detection of neuron-specific ELAV-like-positive cells in the peripheral blood of patients with small-cell lung cancer. Cell Oncol. 2008, 30:291-7.
34. Yu JS, Koujak S, Nagase S. PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene. 2008, 27:4657-65.
35. Kutay H, Bai S, Datta J. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem. 2006, 99:671-8.
36. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-33.
37. Zhu S, Si ML, Wu H. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 2007, 282:14328-36.
38. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000, 100:57-70.
39. Volinia S, Calin GA, Liu CG. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006, 103:2257-61.
40. Tam W, Hughes SH, Hayward WS. Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol. 2002, 76:4275-86.
41. Eis PS, Tam W, Sun L. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA. 2005, 102:3627-32.
42. Kluiver J, Poppema S, de Jong D. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005, 207:243-9.
43. Gillis AJ, Stoop HJ, Hersmus R. High-throughput microRNAome analysis in human germ cell tumours. J Pathol. 2007, 213:319-28.
44. Takamizawa J, Konishi H, Yanagisawa K. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-6.
45. Kulshreshtha R, Ferracin M, Wojcik SE. A microRNA signature of hypoxia. Mol Cell Biol. 2007, 27:1859-67.
46. Kaelin WG. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2002, 2:673-82.
47. Camps C, Buffa FM, Colella S. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res. 2008, 14:1340-8.
48. Fasanaro P, D'Alessandra Y, Di S. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem. 2008, 283:15878-83.
49. Selbach M, Schwanhausser B, Thierfelder N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008, 455:58-63.
50. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008, 14:844-52.
51. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007, 67:976-83.
52. Mott JL, Kobayashi S, Bronk SF. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene. 2007, 26:6133-40.
53. Visone R, Russo L, Pallante P. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer. 2007, 14:791-8.
54. Krutzfeldt J, Rajewsky N, Braich R. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005, 438:685-9.